FINWIRES · TerminalLIVE
FINWIRES

Equities Rise Intraday as US-Iran Ceasefire Holds Amid Hormuz Uncertainty

-- US benchmark equity indexes were higher intraday as a recent two-week ceasefire between Washington and Iran appeared to be holding, though oil prices rebounded as access to the Strait of Hormuz remained restricted.

The Dow Jones Industrial Average and the Nasdaq Composite were up 0.8% each at 48,279.5 and 22,811.7, respectively, after midday Thursday. The S&P 500 added 0.7% to 6,829. Barring energy, all sectors were in the green, led by consumer discretionary.

West Texas Intermediate crude was up 2.3% at $96.54 a barrel intraday. The benchmark hit up to $102.70 a barrel earlier in the session. Brent crude edged up 0.6% to $94.96 per barrel.

The rebound in oil prices follows the sharpest one-day pullback since 2020 in the previous session as the US and Iran agreed to temporarily halt hostilities that had gripped the Middle East since the end of February.

"The Strait of Hormuz is not open," Abu Dhabi National Oil Chief Executive Sultan Al Jaber said in a LinkedIn post Thursday. "Access is being restricted, conditioned and controlled."

Iranian state media previously reported that transit through the strait was halted following Israeli attacks on Lebanon. Israeli Prime Minister Benjamin Netanyahu said the country would negotiate with Lebanon on disarming Hezbollah, CNN reported Thursday.

"We continue to contend that actual transit levels through the waterway will remain significantly depressed given that Iran is insisting vessels must coordinate with its military or face destruction," RBC Capital Markets said in a note.

Officials from Washington and Tehran are expected to meet this weekend in Pakistan, which helped broker the truce.

US Treasury yields were lower intraday, with the 10-year rate down two basis points at 4.27% and the two-year rate dropping 3.4 basis points to 3.76%.

In economic news, US inflation accelerated sequentially in February as real consumer spending edged higher, with analysts expecting price pressures to intensify due to the spillover effects of the Middle East conflict.

The Federal Reserve's preferred inflation metric -- which excludes food and energy -- rose 0.4% month over month, unchanged from January's reading. Annual growth slowed to 3% from 3.1%. All inflation prints met estimates in Bloomberg-compiled surveys.

"With headline inflation likely to test 4% soon, there is little chance the Fed will ease policy in the near term," BMO Capital Markets said in a note.

Weekly applications for unemployment insurance in the US rose more than expected, while continuing claims reached the lowest level since May 2024, government data showed.

"The latest jobless claims data offer no evidence that the (US-Israel) war with Iran has had a notable impact on the labor market," Oxford Economics said in a note. "We don't think an upside surprise in one week is sending a signal that labor market conditions are softening."

In company news, CoreWeave (CRWV) agreed to supply artificial intelligence cloud capacity to Meta Platforms (META) in a $21 billion deal as the companies expanded their partnership amid robust demand for infrastructure supporting AI workloads. CoreWeave shares were up 6.1% intraday, while Meta rose 3%.

Ares Management (ARES) agreed to acquire and take private Whitestone REIT (WSR) in an all-cash deal worth about $1.7 billion. Whitestone shares jumped 11%, while Ares advanced 0.5%.

Chevron (CVX) said it expected higher commodity prices driven by the Middle East conflict to boost first-quarter earnings in its upstream segment by up to $2.2 billion, though timing impacts could weigh on the oil giant's bottom line. The company's shares were down 1.4% intraday, among the worst performers on the Dow.

Gold was up 0.9% at $4,819 per troy ounce, while silver advanced 1.5% to $76.49 per ounce.

Related Articles

Australia

Magnite Says Selected as Hearst News' Preferred Deal Partner for High-Impact Advertising Formats

Magnite (MGNI) said Tuesday it has been selected by Hearst News as a preferred deal partner for high-impact advertising formats across web and CTV inventory.Magnite said it also signed a partnership with Hearst News to support its video advertising operations using the SpringServe platform.Magnite shares were down over 5% in Tuesday trading.Price: $13.31, Change: $-0.70, Percent Change: -4.96%

$MGNI
Asia Markets

European Stocks Track Lower in Tuesday Trading; Euro Area Economic Sentiment Plunges

The European stock markets were tracking lower in Tuesday trading as The Stoxx Europe was declining 0.4% lower, Germany's DAX was off 0.5%, the FTSE 100 was down 1%, France's CAC declined 1.1%, and the Swiss Market Index was 1% lower.Euro area economic outlook sentiment deteriorated sharply in April, according to the April ZEW Financial Market Survey, falling 11.9 points from March to -20.4. The reading was far lower than analyst expectations of -12.7, according to Bloomberg.Aerospace and defense stocks are tumbling in Tuesday trading as Rolls-Royce and BAE Systems dropped 6% and 4.2% respectively in London. Safran and Thales fell 5.9% and 5.6% respectively in Paris. MTU Aero Rheinmetall was off 3.5% in Frankfurt, while Leonardo lost 5% in Milan.In corporate news, Shell faces a fresh lawsuit by a Dutch climate activist organization demanding it immediately end its investments in new oil and gas projects, Reuters reported Tuesday, citing court documents."Shell must stop bringing new oil and gas fields into production. This is necessary to protect us from Shell's climate-disrupting activities," Friends of the Earth Netherlands, or Milieudefensie, said in the filing, Reuters reported.In a statement posted to its website, Shell called the case "unrealistic, unreasonable," and "fundamentally misplaced," adding that "it ignores the role oil and gas will continue to play over the coming decades as renewables become more widely available."Shares of the British oil and gas company were flat in London.Barclays is facing scrutiny from UK regulators over its use of significant risk transfer, or SRT, transactions, Bloomberg reported Tuesday, citing unnamed sources.The review, known as a Section 166 probe, has been requested by the Prudential Regulation Authority, the supervisory arm of the Bank of England, according to the publication. The report says the bank has commissioned an independent review of its practices.Barclays did not immediately respond to' request for comment.Shares of the British bank were off 1.1% in London.BHP is looking to pursue large-scale copper exploration in Zambia, Reuters reported Tuesday, citing the country's mines ministry.The company is targeting major deposits that are harder to detect using traditional methods, focusing on deeply buried or geologically concealed resources, the mines ministry quoted Campbell McCuaig, BHP's head of global generative exploration, as saying, Reuters reported.BHP did not immediately respond to' request for comment.Shares of the mining company were declining 1.4% in London.AstraZeneca said Tuesday a phase 3 trial of Ultomiris in adults with Immunoglobulin A nephropathy, a rare kidney disease, met its primary endpoint.The study showed a statistically significant reduction in proteinuria, based on 24-hour urine protein creatinine ratio at week 34, the company said.AstraZeneca said it plans to submit the data to regulatory authorities while continuing the trial.Shares of the British pharmaceutical company were losing more than 2% in London.Rio Tinto said late Monday its Q1 global iron ore production was 82.8 million metric tonnes, up 12% year over year.Iron ore sales for the quarter rose 2% from a year earlier to 75.7 million metric tonnes.For 2026, the company continues to expect global iron ore sales of 343 million metric tonnes to 366 million metric tonnes.Shares of Rio Tinto were down 1.4% in London.

Australia

Agenus Names BAP Pharma as Global Partner for Botensilimab Plus Balstilimab Access Programs

Agenus (AGEN) said Tuesday it appointed BAP Pharma as the company's global partner for botensilimab plus balstilimab authorized global access programs.These programs include France's Autorisation d'Acces Compassionnel pathway as well as paid named-patient programs in select countries outside the US. Under the arrangement, BAP Pharma will coordinate global access operations, including program requests, logistics, case coordination and related payment processing.Financial terms related to the collaboration were not disclosed.Shares of Agenus were down 7.7% in Tuesday trading.Price: $4.08, Change: $-0.34, Percent Change: -7.69%

$AGEN